School of Public Health, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China; Key Laboratory of Human Genetics and Environmental Medicine, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China.
Department of Oncology, Yixing Hospital Affiliated to Medical College of Yangzhou University, Yixing 214200, Jiangsu, China.
J Hazard Mater. 2024 Jul 15;473:134690. doi: 10.1016/j.jhazmat.2024.134690. Epub 2024 May 21.
N-Nitroso compounds (NOCs) are recognized as important factors that promote gastric cancer development, but the specific effects and potential mechanisms by which NOC exposure promotes gastric cancer are still poorly understood. In this study, we explored the effects and potential molecular mechanisms of NOCs on the promotion of gastric cancer using methylnitronitrosoguanidine (MNNG), a classical direct carcinogen of NOC. The results of in vivo and in vitro experiments showed that chronic and low-concentration MNNG exposure significantly promoted the malignant progression of tumors, including cell migration, cell invasion, vasculogenic mimicry (VM) formation, cell spheroid formation, stem cell-like marker expression, and gastric cancer growth and metastasis. Mechanistically, we revealed that demethylase ALKBH5 regulated the level of the N6‑methyladenosine (m6A) modification in the 3'UTR and CDS region of the ZKSCAN3 mRNA to promote ZKSCAN3 expression, mediated the binding of ZKSCAN3 to the VEGFA promoter region to regulate VEGFA transcription, and participated in MNNG-induced gastric cancer cell migration, invasion, VM formation, cell spheroid formation, stem cell-like marker expression and ultimately gastric cancer progression. In addition, our study revealed that ALKBH5-ZKSCAN3-VEGFA signaling was significantly activated during MNNG-induced gastric carcinogenesis, and further studies in gastric cancer patients showed that ALKBH5, ZKSCAN3, and VEGFA expression were upregulated in cancers compared with paired gastric mucosal tissues, that ALKBH5, ZKSCAN3, and VEGFA could serve as important biomarkers for determining patient prognosis, and that the molecular combination showed greater prognostic value. These findings provide a theoretical basis for developing gastric cancer interventions for NOCs and for determining gastric cancer progression.
N-亚硝基化合物(NOCs)被认为是促进胃癌发展的重要因素,但 NOC 暴露促进胃癌的具体作用和潜在机制仍知之甚少。在这项研究中,我们使用甲基亚硝胺(MNNG)——一种经典的 NOC 直接致癌物,探索了 NOC 对胃癌促进作用的影响及其潜在的分子机制。体内和体外实验的结果表明,慢性低浓度 MNNG 暴露显著促进了肿瘤的恶性进展,包括细胞迁移、细胞侵袭、血管生成拟态(VM)形成、细胞球体形成、干细胞样标志物表达以及胃癌的生长和转移。在机制上,我们揭示了去甲基酶 ALKBH5 通过调节 ZKSCAN3 mRNA 的 3'UTR 和 CDS 区域中的 N6-甲基腺苷(m6A)修饰水平来调控 ZKSCAN3 的表达,介导 ZKSCAN3 与 VEGFA 启动子区域结合以调节 VEGFA 转录,并参与 MNNG 诱导的胃癌细胞迁移、侵袭、VM 形成、细胞球体形成、干细胞样标志物表达以及最终的胃癌进展。此外,我们的研究揭示了 ALKBH5-ZKSCAN3-VEGFA 信号通路在 MNNG 诱导的胃癌发生过程中显著激活,并且对胃癌患者的进一步研究表明,与配对的胃黏膜组织相比,ALKBH5、ZKSCAN3 和 VEGFA 在癌症中表达上调,ALKBH5、ZKSCAN3 和 VEGFA 可作为确定患者预后的重要生物标志物,并且分子组合显示出更大的预后价值。这些发现为开发针对 NOC 的胃癌干预措施和确定胃癌进展提供了理论依据。